Systematic review finds potential in glutamatergic medications for OCD treatment

A systematic review and meta-analysis from the Harvard T.H. Chan School of Public Health reported a large effect of glutamatergic medications on improving symptoms of obsessive-compulsive and related disorders (OCRDs). The study evaluated outcomes across 27 randomized clinical trials, finding significant benefits, particularly for obsessive-compulsive disorder (OCD).

Building digital twins and hearts: New technology could predict various health outcomes

Imagine having a digital carbon copy of yourself that physicians could use to predict long-term risks for disease, assess how your body may respond to treatment, and simulate surgeries in advance. A virtual twin may sound as far-fetched as robotic surgery and self-driving cars once did, but researchers are studying how to turn this vision into a reality.